Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/20/2024 | $7.50 → $7.00 | Equal Weight → Underweight | Wells Fargo |
| 7/19/2024 | Neutral | BTIG Research | |
| 3/4/2024 | $11.00 → $7.00 | Buy → Underperform | BofA Securities |
| 12/6/2023 | $10.50 | Neutral | UBS |
| 12/5/2023 | Mkt Outperform → Mkt Perform | JMP Securities | |
| 9/13/2023 | $10.00 | Equal Weight | Wells Fargo |
| 8/18/2023 | Outperform → Mkt Perform | Raymond James | |
| 4/25/2023 | Buy → Neutral | BTIG Research |
144 - Ares Commercial Real Estate Corp (0001529377) (Subject)
8-K - Ares Commercial Real Estate Corp (0001529377) (Filer)
10-Q - Ares Commercial Real Estate Corp (0001529377) (Filer)
Ares Commercial Real Estate Corporation (NYSE:ACRE) (the "Company") today announced the 2025 tax treatment for the Company's common stock distributions (CUSIP # 04013V-10-8). Form 1099 Reference: Box 1a Box 1b Box 2a Box 3 Box 5 Record Date Payment Date Cash Distribution Per Share Allocable to 2025 Total Ordinary Dividends Qualified Dividends (1) Total Capital Gain Distributions Nondividend Distributions Section 199A Dividends (1) 12/31/2024 1/15/2025 $0.2500(2) $0.2500 $0.0000 $0.0000 $0.0000 $0.2500 $0.0000 3/31/2025 4/15/2025 $0
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it will report earnings for the fourth quarter and full year ended December 31, 2025 on Tuesday, February 10, 2026 prior to the opening of the New York Stock Exchange. Ares Commercial Real Estate Corporation will hold its webcast/conference call on the same day at 12:00 p.m. Eastern Time to discuss its fourth quarter and full year ended December 31, 2025 financial results. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Home page of the Investor Resources section of our website at http://www.arescre.com. Please visit the websit
Third quarter GAAP net income of $4.7 million or $0.08 per diluted common share and Distributable Earnings(1) of $5.5 million or $0.10 per diluted common share - Subsequent to the three months ended September 30, 2025 - Closed $271 million of new loan commitments Declared fourth quarter 2025 dividend of $0.15 per common share Ares Commercial Real Estate Corporation (the "Company") (NYSE:ACRE), a specialty finance company primarily engaged in directly originating and investing in commercial real estate assets, reported generally accepted accounting principles ("GAAP") net income of $4.7 million or $0.08 per diluted common share and Distributable Earnings(1) of $5.5 million or $0.10 per d
Wells Fargo downgraded Ares Commercial Real Estate from Equal Weight to Underweight and set a new price target of $7.00 from $7.50 previously
BTIG Research resumed coverage of Ares Commercial Real Estate with a rating of Neutral
BofA Securities downgraded Ares Commercial Real Estate from Buy to Underperform and set a new price target of $7.00 from $11.00 previously
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)
SC 13G/A - Ares Commercial Real Estate Corp (0001529377) (Subject)
SC 13G/A - Ares Commercial Real Estate Corp (0001529377) (Subject)
SC 13G - Ares Commercial Real Estate Corp (0001529377) (Subject)
Ares Commercial Real Estate Corporation (NYSE:ACRE) (the "Company") today announced the 2025 tax treatment for the Company's common stock distributions (CUSIP # 04013V-10-8). Form 1099 Reference: Box 1a Box 1b Box 2a Box 3 Box 5 Record Date Payment Date Cash Distribution Per Share Allocable to 2025 Total Ordinary Dividends Qualified Dividends (1) Total Capital Gain Distributions Nondividend Distributions Section 199A Dividends (1) 12/31/2024 1/15/2025 $0.2500(2) $0.2500 $0.0000 $0.0000 $0.0000 $0.2500 $0.0000 3/31/2025 4/15/2025 $0
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it will report earnings for the fourth quarter and full year ended December 31, 2025 on Tuesday, February 10, 2026 prior to the opening of the New York Stock Exchange. Ares Commercial Real Estate Corporation will hold its webcast/conference call on the same day at 12:00 p.m. Eastern Time to discuss its fourth quarter and full year ended December 31, 2025 financial results. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Home page of the Investor Resources section of our website at http://www.arescre.com. Please visit the websit
Third quarter GAAP net income of $4.7 million or $0.08 per diluted common share and Distributable Earnings(1) of $5.5 million or $0.10 per diluted common share - Subsequent to the three months ended September 30, 2025 - Closed $271 million of new loan commitments Declared fourth quarter 2025 dividend of $0.15 per common share Ares Commercial Real Estate Corporation (the "Company") (NYSE:ACRE), a specialty finance company primarily engaged in directly originating and investing in commercial real estate assets, reported generally accepted accounting principles ("GAAP") net income of $4.7 million or $0.08 per diluted common share and Distributable Earnings(1) of $5.5 million or $0.10 per d
Ares Commercial Real Estate Corporation announced today that it has appointed Rebecca Parekh to its Board of Directors, effective immediately. Ms. Parekh's appointment expands the Board from seven to eight members, including six independent board members. Ms. Parekh is the Co-Founder and Chief Executive Officer of The Well, a series of wellness facilities. Previously, she served as the Chief Operating Officer for Deepak Chopra Radical Well-Being, LLC. Prior to that, Ms. Parekh spent ten years at Deutsche Bank Securities, Inc., focused primarily on structured credit where she held various positions, including Head of the U.S. Private Institutional Client Group and Head of Cross Product Sale